Landmark 2026 Clinical Study Validates At-Home Quantitative Multi-Hormone Monitoring Against Ultrasound Gold Standard

Data ReadoutpositiveMiraPositive

AI Analysis

Summary

A peer-reviewed study published in Reproductive BioMedicine Online validates Mira's at-home LH monitoring system, achieving 96% agreement with transvaginal ultrasound, demonstrating clinical equivalence for decentralized reproductive care.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Peer-reviewed study published in Reproductive BioMedicine Online demonstrates 96% agreement between Mira at-home LH measurements and transvaginal ultrasound

Importance:6/10

Sentiment:

0.85

reproductive healthat-home testingdecentralized careclinical validationhormone monitoring

Read the original article

Published by PR Newswire Clinical Trials on September 1, 2026 12:04 PM

Read Original